Getting your ADCs to the clinic: Considerations for early stage development 2013

Getting your ADCs to the clinic: Considerations for early stage development 2013 is a seminar that provides guidance on the development of antibody-drug conjugates (ADCs), including:

• Key parameters for non-clinical studies to support a Phase 1 clinical trial
• CMC issues during the development of ADCs, with a particular focus on the assessment and control of the quality of such products
• How to create an early phase product development plan that meets regulatory expectations
• The factors that influence the choice of conjugate and linker types